The Feinstein Institutes
The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, operating 50 labs and 3,000-5,000 clinical studies with 6,300 researchers. It is the global leader in bioelectronic medicine, advancing vagus nerve stimulation and molecular medicine for sepsis, cancer, autoimmune, and inflammatory diseases.
- Company typePrivate
- Founded1999
- HeadquartersManhasset, United States
- Headcount5,001–10,000
- GTM typeB2B
- OfferingServices
What The Feinstein Institutes does
The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, New York's largest healthcare provider. Operating 50 research labs and conducting 3,000-5,000 active clinical research studies with approximately 6,300 researchers and staff, the institute is organized around six specialized research institutes covering behavioral science, bioelectronic medicine, cancer, health system science, molecular medicine, and translational research. It is recognized as the global scientific leader in bioelectronic medicine, a field that uses electronic devices — particularly vagus nerve stimulation — to treat inflammatory and stress-related diseases as an alternative to pharmaceutical intervention.
The institute's core scientific platforms include the FDA-approved SetPoint System for rheumatoid arthritis (co-developed by Feinstein CEO Dr. Kevin J. Tracey through SetPoint Medical), novel peptide drug candidates (P2-1 for sepsis and rheumatoid arthritis; NDI for sepsis-induced acute lung injury), the eCIRP/MFG-E8 inflammation research program, ultrasound-based neuromodulation for obesity (in collaboration with GE Research), and proprietary discoveries in brain circuit control of inflammation and stress. Education and training are delivered through the Elmezzi Graduate School of Molecular Medicine, MD/PhD programs with Cold Spring Harbor Laboratory and the Zucker School of Medicine, and a Summer Student Intern Program. The institute also publishes two peer-reviewed journals (Molecular Medicine and Bioelectronic Medicine) and administers the annual Ross Prize in Molecular Medicine and Cerami Award in Translational Medicine.
Revenue is generated through a hybrid nonprofit model: NIH and federal research grants (including disclosed awards of $6.1M for red cell disorders, $3M from NINDS, and $1.8M MSTP training grant), institutional support from parent Northwell Health, philanthropy, educational program tuition, and technology licensing (e.g., SetPoint Medical). Primary stakeholders are patients participating in clinical trials, physician-scientist trainees, collaborating academic institutions, and federal funders. The institute holds 17 patents associated with its senior scientific leadership and has published over 500 peer-reviewed articles, with Dr. Ping Wang recognized as the second-most-cited sepsis scientist globally.
The Feinstein Institutes firmographics
Firmographics- Name
- The Feinstein Institutes
- Legal name
- The Feinstein Institutes for Medical Research
- Website
- https://feinstein.northwell.edu
- Company type
- Private
- Founded year
- 1999
- Operating status
- Operating
- Headcount range
- 5,001–10,000 employees
- Short description
- The Feinstein Institutes for Medical Research is the nonprofit research division of Northwell Health, operating 50 labs and 3,000-5,000 clinical studies with 6,300 researchers. It is the global leader in bioelectronic medicine, advancing vagus nerve stimulation and molecular medicine for sepsis, cancer, autoimmune, and inflammatory diseases.
- Ownership category
- akta.pro rank
The Feinstein Institutes industry classification
Industry- Product category
- Medical Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Research and Development in the Physical, Engineering, and Life Sciences (54171), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071)
- akta.pro primary industry
- Biomedical Sciences & Medical Research Institutes (University-Based) (EDAHAGAI)
- akta.pro secondary industries
- Academic Medical Centers & Teaching Hospitals (University-Affiliated) (EDAHAGAA), Health & Biomedical Research Universities (Academic Medical Center–Affiliated) (EDAHABAC)
Keywords
Where The Feinstein Institutes is headquartered
LocationHeadquarters
- HQ city
- Manhasset
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
The Feinstein Institutes business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Revenue model
- NIH Research Grants: Primary funding source from National Institutes of Health grants for specific research projects including red cell disorders ($6.1M, 7-year grant), physician scientist training ($1.8M, 5-year MTSP grant), and various R01 grants for sepsis, radiation research, and other inflammatory conditions.
- Northwell Health Institutional Support: Operational and strategic support from parent organization Northwell Health, the largest health care provider in New York.
- Educational Programs: Revenue from educational programs including the Elmezzi Graduate School of Molecular Medicine, summer student internship programs, and visiting scientist programs.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
The Feinstein Institutes product offering
Product offeringCore offering
The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It conducts basic, translational, and clinical research across six specialized institutes covering bioelectronic medicine, molecular medicine, cancer, behavioral science, health system science, and translational research. It runs 50 research labs and 3,000-5,000 clinical research studies, and offers graduate-level education programs including the Elmezzi Graduate School of Molecular Medicine and physician-scientist training.
Product overview
The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It is organized around six specialized research institutes covering behavioral science, bioelectronic medicine, cancer research, health system science, molecular medicine, and translational research. The organization operates 50 research labs conducting over 5,000 clinical research studies with 6,300 researchers and staff. Key offerings include advanced medical education programs (Elmezzi Graduate School, Summer Intern Program, Visiting Scientists Program), peer-reviewed journals (Molecular Medicine, Bioelectronic Medicine), prestigious awards (Ross Prize, Cerami Award), and digital health platforms including the MyNorthwell patient portal. The institutes are the global scientific leader in bioelectronic medicine, pioneering vagus nerve stimulation therapies including the FDA-approved SetPoint System for rheumatoid arthritis.
Differentiator
Problem solved
Functional benefit
Products and services
- Elmezzi Graduate School of Molecular Medicine PhD program for physicians seeking careers in biomedical research, training students to discover causes of human diseases and translate research into diagnostic and therapeutic solutions.
- Summer Student Intern Program Mentored program providing undergraduate students with hands-on experience in disease-oriented research, including workshops, seminars and academic poster presentation.
- Visiting Scientists & Scholars Program Program allowing scientists and students to volunteer in research programs under mentorship of Feinstein faculty researchers.
- Medical Marvels Program Collaborative research competition for Long Island high school students (grades 9-10) encouraging STEM career pathways, established by Feinstein Institutes and Center for Workforce Readiness.
- Molecular Medicine Journal Peer-reviewed, open-access journal published by Feinstein Institutes achieving all-time high impact factor, recognizing outstanding biomedical research.
- Bioelectronic Medicine Journal Peer-reviewed journal published in collaboration with BMC/Springer Nature covering the emerging field of bioelectronic medicine and neural modulation therapies.
Quantifiable outcome
- Discovery of brain circuit linking inflammation and stress response, published in Journal of Experimental Medicine
- +5 more outcomes
Companies that use The Feinstein Institutes
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles4 records
The Feinstein Institutes technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability5 records
Feature5 records
The Feinstein Institutes partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core.
- SetPoint MedicalcoreBiotech company co-founded by Dr. Kevin J. Tracey that developed the SetPoint System, an implantable vagus nerve stimulation device for rheumatoid arthritis. The FDA-approved device was implanted at Northwell's North Shore University Hospital in August 2025 as the nation's first such implantation.
- GE ResearchcoreCollaboration between Feinstein Institutes and GE Research to demonstrate ultrasound stimulation as a noninvasive treatment for obesity. GE provided novel ultrasound technology for peripheral nerve modulation, while Feinstein researchers conducted preclinical studies showing therapeutic effects on body weight, food intake, and metabolic markers. Research published in Scientific Reports.
- Cold Spring Harbor LaboratorycoreStrategic partnership where Zucker School of Medicine MD/PhD students can conduct PhD research at Cold Spring Harbor Laboratory, home to eight Nobel Prize winners. Students benefit from state-of-the-art facilities and collaboration with renowned scientists in cancer, neuroscience, plant biology, and quantitative biology.
- Donald and Barbara Zucker School of Medicine at Hofstra/NorthwellcoreThe Zucker School of Medicine is built on established medical education programs of Northwell Health and robust research conducted at the Feinstein Institutes. Students have opportunities to complete MD/PhD portions of their degree at Feinstein Institutes or partner institutions.
- Northwell HealthcoreThe Feinstein Institutes is the research arm of Northwell Health, New York's largest health care provider. This parent-subsidiary relationship provides institutional support, clinical trial infrastructure, and access to patient populations across the health system's facilities in New York, Hudson Valley, and western Connecticut.
Scale indicators10 records
Recent moves6 records
Expansion highlights6 records
The Feinstein Institutes competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key highlights7 records
Customer concentration
The Feinstein Institutes social profiles
Digital presenceThe Feinstein Institutes financial estimates
Financial estimateRevenue estimate
Valuation estimate
The Feinstein Institutes leadership team
Management profileNumber of profiles
Profiles12 records
The Feinstein Institutes funding detail
Funding detailFunding overview
Funding rounds2 records
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
The Feinstein Institutes M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about The Feinstein Institutes
What does The Feinstein Institutes do?
The Feinstein Institutes for Medical Research is the research arm of Northwell Health, New York's largest healthcare provider. It conducts basic, translational, and clinical research across six specialized institutes covering bioelectronic medicine, molecular medicine, cancer, behavioral science, health system science, and translational research. It runs 50 research labs and 3,000-5,000 clinical research studies, and offers graduate-level education programs including the Elmezzi Graduate School of Molecular Medicine and physician-scientist training.
Is The Feinstein Institutes a public or private company?
The Feinstein Institutes is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was The Feinstein Institutes founded?
The Feinstein Institutes was founded in 1999. It employs 5,001 to 10,000 people.
Where is The Feinstein Institutes based?
The Feinstein Institutes is headquartered in Manhasset, United States, in the North America region.
How does The Feinstein Institutes make money?
Three revenue lines are on record. NIH Research Grants are the primary driver. The others are northwell Health Institutional Support and educational Programs.
Does The Feinstein Institutes have an API?
No public API is recorded for The Feinstein Institutes.
What industry is The Feinstein Institutes in?
The Feinstein Institutes's product category is Medical Research Services. Its primary akta.pro industry code is EDAHAGAI, Biomedical Sciences & Medical Research Institutes (University-Based), with a secondary code of EDAHAGAA, Academic Medical Centers & Teaching Hospitals (University-Affiliated). Its NAICS code is 541714 and its SIC code is 8731.